Biotech Values

[jq1234]

Why wouldn't they [Lupin] have brought their enox drug to the U.S. themselves?

Lupin licensed from ItalFarmaco to market it in Indian market only. ItalFarmaco had marketed/licensed in/to several other countries under different brand names. Maybe ItalFarmaco licensed US rights to someone else already !?

Lupin announced that it signed an in-licensing agreement with ItalFarmaco, a leading Italian pharmaceutical company. Lupin will exclusively market their cardiovascular critical care product, enoxaparin sodium injection, in pre-filled syringes under the brand name Lupenox in the Indian market.